Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
Top Cited Papers
- 1 July 2014
- journal article
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 2 (7), 566-572
- https://doi.org/10.1016/s2213-2600(14)70101-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological dataBMC Pulmonary Medicine, 2013
- Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literatureEuropean Respiratory Review, 2012
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary FibrosisNew England Journal of Medicine, 2012
- The rising incidence of idiopathic pulmonary fibrosis in the UKThorax, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis: A Population-Based StudyChest, 2010
- Idiopathic pulmonary fibrosis—results from a Japanese nationwide epidemiological survey using individual clinical recordsRespirology, 2008
- Idiopathic pulmonary fibrosisOrphanet Journal of Rare Diseases, 2008
- Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003American Journal of Respiratory and Critical Care Medicine, 2007
- The Clinical Course of Patients with Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 2005